| Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127) |
|---|
| 01/08/2004 | WO2004003550A2 Individualization of therapy with anticoagulants |
| 01/08/2004 | WO2004003510A2 Fluorescent dyes, energy transfer couples and methods |
| 01/08/2004 | WO2004002980A2 Method for synthesizing coumarin and the derivatives thereof |
| 01/08/2004 | WO2004002965A1 Arylcarbonylpiperazines and heteroarylcarbonylpiperazines and the use thereof for treating benign and malignant tumour diseases |
| 01/08/2004 | WO2004002939A2 Aminoalcohol derivatives |
| 01/08/2004 | WO2004002470A1 Compounds useful for the inhibition of aldh |
| 01/08/2004 | WO2003095442A3 Process for the preparation of 3-isochromanone |
| 01/08/2004 | WO2002080164A9 Optical recording medium |
| 01/08/2004 | WO2002053522A3 Novel estrogen receptor ligands and methods i |
| 01/08/2004 | US20040006248 Nitration of conjugated alkene by reacting with mixture of an inorganic nitrite and iodine in the presence of an oxidising agent |
| 01/08/2004 | US20040006236 Diaminopropionic acid derivatives |
| 01/08/2004 | US20040006143 Aminoalcohol derivatives |
| 01/08/2004 | US20040006049 For therapy of prostatitis, benign prostate hyperplasia or prostate cancer |
| 01/08/2004 | US20040005637 Intermediate products coupled to solid polymeric support suitable for synthesis of heterocyclic compounds in simple and fast methods on solid phase; for synthesis of heterocycles with large structural diversity in high yields |
| 01/08/2004 | DE10227483A1 Verfahren zur Herstellung von 11(12)-Pentadecen-15-oliden A process for the preparation of 11 (12) -pentadecen-15-olides |
| 01/08/2004 | CA2492065A1 Aminoalcohol derivatives_as b3 adrenergic receptor agonist |
| 01/08/2004 | CA2491089A1 Compounds useful for the inhibition of aldh |
| 01/07/2004 | EP1377978A2 Optical data carrier whose information layer contains a light-absorbing compound having a number of chromophoric centers |
| 01/07/2004 | EP1377976A2 Optical data carrier that contains a merocyanine dye as the light-absorbing compound in the information layer |
| 01/07/2004 | EP1377975A2 Optical data medium containing, in the information layer, a dye as a lightabsorbing compound and having a protective covering layer of predetermined thickness |
| 01/07/2004 | EP1377974A1 Optical data carrier containing a xanthene dye in the information layer thereof as a light-absorbing compound |
| 01/07/2004 | EP1377973A1 Optical data memories containing an axially substituted co-phthalocyanine in the information layer that can be written with light |
| 01/07/2004 | EP1377971A1 Optical data carrier that contains a cationic aminoheterocyclic dye as the light-absorbing compound in the information layer |
| 01/07/2004 | EP1377970A1 Optical data carrier containing a cyclizable compound in the information layer |
| 01/07/2004 | EP1377968A2 Optical data carrier that contains a heterocyclic azo dye as the light-absorbing compound in the information layer |
| 01/07/2004 | EP1377287A2 Proanthocyanidins for the treatment of amyloid and alpha-synuclein diseases |
| 01/07/2004 | EP1150968B1 Method for producing phytosterols |
| 01/07/2004 | CN1466454A Method of treating symptons of common cold allergic rhinitis and infections relating to the respiratory tract |
| 01/07/2004 | CN1465573A Method for extracting proanthocyanidines |
| 01/07/2004 | CN1465572A Method for purifying monomer of epigallocatechingallate (EGCG) |
| 01/07/2004 | CN1465571A Method for extracting genistein |
| 01/07/2004 | CN1465570A Process for preparing genistein, medicinal composition and use thereof |
| 01/07/2004 | CN1465569A Method for raising total flavone content in propolis |
| 01/06/2004 | US6673945 Process for production of high purity tocopherols |
| 01/06/2004 | US6673944 Conducted in a polar organic solvent, preferably ethanol, using a volatilizable base, preferably sodium carbonate, at low temperature. drying the final product is accomplished at low temperature to avoid decomposition |
| 01/06/2004 | US6673813 Methods for identifying and treating resistant tumors |
| 01/06/2004 | US6673557 Methods of treatment of eye trauma and disorders |
| 01/06/2004 | US6673257 Blends employing at least two organic compounds having known melt temperatures, exhibit improved thermal properties and performance characteristics |
| 01/06/2004 | CA2301990C New substitute dimerized derivatives, process for preparing them, and pharmaceutical compounds containing them |
| 01/02/2004 | EP1375491A1 Process for the preparation of 11(12)-pentadecen-15-olides |
| 01/02/2004 | EP1374234A1 Optical data support comprising a hemicyanin dye in the information layer as light-absorbing compound |
| 01/02/2004 | EP1374233A1 Optical data carrier that contains a triazacyanine dye as the light-absorbing compound in the information layer g |
| 01/02/2004 | EP1373261A2 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors |
| 01/02/2004 | EP1373244A2 Substituted benzopyranones as telomerase inhibitors |
| 01/02/2004 | EP1373243A1 Aminoflavone compounds, compositions, and methods of use thereof |
| 01/02/2004 | EP1373242A1 Dimeric isoflavones |
| 01/02/2004 | EP1373192A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad |
| 01/02/2004 | EP1373183A1 Permanent surface modifiers |
| 01/02/2004 | EP1372682A2 Catechins for the treatment of fibrillogenesis in alzheimer's disease, parkinson's disease, systemic aa amyloidosis, and other amyloid disorders |
| 01/02/2004 | EP1372645A1 Reconstitutable parenteral composition containing a cox-2 inhibitor |
| 01/02/2004 | EP1372638A1 Functional role for cannabinoids in autonomic stability during sleep |
| 01/02/2004 | EP0979103B1 Light imaging contrast agents |
| 01/01/2004 | US20040002539 Enzyme inhibitors; anticoagulants; blood collecting device |
| 01/01/2004 | US20040002538 4-Thio coumarins |
| 01/01/2004 | US20040002491 Melatonergic receptors |
| 01/01/2004 | US20040002490 Melatonergic receptors |
| 01/01/2004 | US20040002123 Detection of transmembrane potentials by optical methods |
| 12/31/2003 | WO2004000797A1 Alpha-sulfonylamino-acetonitriles |
| 12/31/2003 | WO2004000792A1 A process for the preparation of 3-cyano-1-naphthoic acid and some analogues thereof |
| 12/31/2003 | WO2004000306A1 Novel antimalarial agent |
| 12/31/2003 | WO2003077832A3 Dexanabinol and dexanabinol analogs regulate inflammation related genes |
| 12/31/2003 | CN1463981A Soybean segregative scleroprotein clean production method |
| 12/31/2003 | CN1463970A Process for preparing silymarin |
| 12/31/2003 | CN1132830C Method for extracting protein, short peptide, nucleic acid, isoflavone, saponin and oligosaccharide by using high and low temperature soybean cake |
| 12/31/2003 | CN1132807C Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid compounds |
| 12/31/2003 | CA2445515A1 Transcription factor modulating compounds and methods of use thereof |
| 12/30/2003 | US6670391 For inhibiting both immediate and delayed type allergic reactions; side effect reduction |
| 12/30/2003 | US6670390 Polyphenols and procyanidins; increasing nitric oxide synthesis |
| 12/30/2003 | US6670383 Pyranocoumarin compounds as a novel pharmacophore with anti-TB activity |
| 12/30/2003 | US6670376 Aryl aniline β2 adrenergic receptor agonists |
| 12/30/2003 | US6670359 Such as (S)-N-(5-(4-Methylpiperazin-1-yl)-3,4-dihydro-2H-1-benzopyran-3-yl)-4 -morpholinobenzamide for treatment of mood/anxiety/eating disorders |
| 12/30/2003 | US6670358 Substituted thioacetamides |
| 12/30/2003 | US6670346 Treatment and/or inhibition of the development of osteoporosis, breast cancer, hypercholesterolemia, hyperlipidemia or atherosclerosis in susceptible warm-blooded animals including humans, administering selective estrogen |
| 12/30/2003 | US6669952 Composition containing isoflavone material and plant sterol for reducing LDL-cholesterol |
| 12/30/2003 | CA2291931C Isochroman compounds and their production process |
| 12/30/2003 | CA2291732C A salt (r)-3-n,n-dicyclobutylamino-8-fluoro-3,4-dihydro-2h-1-benzopyran-5-carboxaminde hydrogen (2r,3r)-tartrate |
| 12/29/2003 | CA2433983A1 Aryl- and heteroarylcarbonylpiperazines and their use for the treatment of benign and malignant oncoses |
| 12/25/2003 | US20030236438 Enantioselective 1,4-addition of aromatic nucleophiles to alpha,beta-unsaturated aldehydes using chiral organic catalysts |
| 12/25/2003 | US20030236410 Cis-4-benzoylamino-6-cyano-or -6-acetyl-3,4-dihydro-2,2-dimethyl-2H- benzo(b)pyran-3-ol, therapeutic agents as anticonvulsants; chemical intermediates from a trans configuration compounds |
| 12/25/2003 | US20030236403 Certain substituted 1-aryl-3-piperazine-1'-yl propanones |
| 12/25/2003 | US20030236268 Process for the preparation of piperidinylaminomethyl trifluoromethyl cyclic ether compounds |
| 12/25/2003 | US20030236227 Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
| 12/25/2003 | US20030235612 Compounds and compositions for delivering active agents |
| 12/25/2003 | CA2391454A1 Cannabinoid extraction method |
| 12/24/2003 | WO2003084916A3 Compounds that modulate ppar activity and methods for their preparation |
| 12/24/2003 | CN1462748A Preparation of 3-(formamide)-7-(methylsulfonyl amine)-6-(phenoxy)-4H-1-(benzopyran)-4-ketone |
| 12/23/2003 | US6667337 Combination therapy for cancer |
| 12/23/2003 | CA2268439C Citrus peel extract as 3-hydroxy-3-methylglutaryl coa(hmg-coa) reductase inhibitor |
| 12/18/2003 | WO2003104216A1 Urotensin ii receptor modulators |
| 12/18/2003 | WO2003103583A2 A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system |
| 12/18/2003 | US20030233002 Synthesis of 2-Acyl substituted chromanes and intermediates thereof |
| 12/18/2003 | US20030232989 Process for the preparation of specific aromatic aldehydes |
| 12/18/2003 | US20030232844 Dihydrobenzopyrans, dihydrobenzothiopyrans, and tetrahydroquinolines for the treatment of cox-2 mediated disorders |
| 12/18/2003 | US20030232809 Preventing or treating acute myocardial infarction, unstable angina and peripheral artery occlusion |
| 12/18/2003 | CA2488609A1 A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system |
| 12/17/2003 | EP1370546A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications |
| 12/17/2003 | EP1370294A2 Use of natural egfr inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth receptor |
| 12/17/2003 | CN1462435A Optical data carrier containing phthalocyanine colouring agent as light absorbing compound in information layer |
| 12/17/2003 | CN1462358A Optical data storage device containing Co-Phthalocyanin complex in optically writable information layer |
| 12/17/2003 | CN1131225C Novel polyoxypropylenpolyoxyethylene vitamin E and preparation thereof |